DBVT Q3 2025 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$4M

Operating Income

-$37M

Net Income

-$33M

EPS (Diluted)

$-1.60

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$516,000

Balance Sheet

Total Assets

$110M

Total Liabilities

$58M

Stockholders' Equity

$53M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	-$4M	$1M	-499.4%
Operating Income	-$37M	-$30M	-21.6%
Net Income	-$33M	-$30M	-8.5%